CRISPR Quest

Where

Virtual

When

{{getUserDateTimeZone("1645725600").singleDate}}
{{getUserDateTimeZone("1645725600").time}} - {{getUserDateTimeZone("1645729200").time}} {{getClientTimeZoneName()}}

About

Last summer Intellia reported the first data showing that CRISPR could be used in the body to combat a disease – in this case, a rare nerve disorder. That early data was so eye-catching it was published in the New England Journal of Medicine.

But what are the next steps? The company’s CEO, John Leonard, joins STAT to lay them out and answer your questions.

Host

More events in "Research"

{{getUserDateTimeZone("1682614800").day}} {{getUserDateTimeZone("1682614800").month}} Virtual Breakout Stars in Science

Each year, STAT chooses a new class of Wunderkinds, showcasing heroes of science and medicine who are in the midst of launching their career…